Jefferies cuts DocMorris on limited upside, shares fall
BUZZ-Jefferies cuts DocMorris on limited upside, shares fall ** DocMorris DOCM.S shares seen down nearly 4% in Julius Baer pre-market indications after Jefferies cut the Swiss online pharmacy to "hold" from "buy"
** Jefferies sees the improved growth and margin outlook as now largely reflected in the current valuation after a "strong" year-to-date share performance
** Stock has risen in value by roughly two thirds since January
** "Momentum remains encouraging, particularly in the German prescription medicine business, however we see limited upside until management provides further evidence of sustainable progress towards its profitability and free cash flow target," the broker writes
** Jefferies lifts PT by 15.8% to CHF 11
($1 = 0.8035 Swiss francs)
(Reporting by Danny Callaghan)
Recent news on DocMorris AG
See all newsBrief: Docmorris AG Revenue And Adjusted EBITDA Guidance For 2026 Increased
Swiss stocks - Factors to watch on October 15
Brief: Docmorris Announces Final Conversion Price And Issue Size Of Its New Convertible Bonds Due 2031
Brief: Docmorris Successfully Completes The Private Placement Of Convertible Bonds Due 2031
Brief: Docmorris AG Convertible Bond Books Covered Throughout Bookbuilding Range, Says Bookrunner